Intercure Ltd. - ordinary shares (INCR)
1.7400
+0.1300 (8.07%)
Intercure Ltd is a prominent player in the global cannabis industry, focusing on the cultivation, production, and distribution of medical cannabis products
The company is dedicated to providing high-quality cannabis solutions for patients, emphasizing the therapeutic benefits of its offerings. With a commitment to innovation and research, Intercure aims to expand its market presence and improve the accessibility of medical cannabis, while also adhering to stringent regulatory standards. Through strategic partnerships and a diverse product portfolio, the company seeks to position itself as a leader in the ever-evolving cannabis market.
![](https://cdn.benzinga.com/files/images/story/2024/09/14/AI-Generated-Image.jpeg?width=1200&height=800&fit=crop)
InterCure Ltd. has shown resilience in its H1 2024 performance despite facing significant challenges according to research by Z&A.
Via Benzinga · September 14, 2024
![](https://cdn.benzinga.com/files/images/story/2024/08/30/cannabis-earnings--money-marijuana-Canna.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · August 30, 2024
![](https://cdn.benzinga.com/files/images/story/2024/07/17/dalle_2024-07-17_17.57.45_-_a_vibrant_and_realistic_painting_in_the_style_of_the_french_revolution_set_in_the_1700s_but_featuring_elements_of_the_modern_cannabis_industry._the_s.jpeg?width=1200&height=800&fit=crop)
Some European cannabis companies are already planning initial public offerings (IPOs) on the Nasdaq, encouraged by the prospect of a less restrictive regulatory environment. The potential rescheduling of cannabis to Schedule III of the Controlled Substances Act and Germany’s recent decriminalization have ignited optimism within the sector.
Via Benzinga · July 18, 2024
![](https://cdn.benzinga.com/files/images/story/2024/05/23/dalle_2024-05-23_16.55.22_-_c.jpeg?width=1200&height=800&fit=crop)
The potential rescheduling of cannabis in the U.S.
Via Benzinga · May 24, 2024
![](https://cdn.benzinga.com/files/images/story/2024/05/02/imagen-digital-720.jpeg?width=1200&height=800&fit=crop)
"Explore InterCure's FY2023 financial results revealing robust revenue growth and operational resilience amidst challenges.
Via Benzinga · May 2, 2024
![](https://cdn.benzinga.com/files/images/story/2024/cannabis-CGC-TLRY-ACB-IGC_2.jpeg?width=1200&height=800&fit=crop)
Discover how InterCure thrives in 2023 with $95.4M revenue, despite challenges, and plans for global expansion into the U.S. and Germany.
Via Benzinga · April 1, 2024
![](https://cdn.benzinga.com/files/images/story/2023/09/01/emilio-takas-_gnvwzjv-jo-unsplash.jpg?width=1200&height=800&fit=crop)
InterCure Ltd. (NASDAQINCR) (TASE: INCR), which is doing business as Canndoc, reported its financial and operating results on Thursday for the three and six months ended June 30, 2023,
Via Benzinga · September 1, 2023
![](/next-assets/images/schema-image-default.png)
Via Benzinga · August 21, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Wednesday's session saw 43 companies set new 52-week lows.
Via Benzinga · July 5, 2023
![](https://cdn.benzinga.com/files/images/story/2023/06/15/cannabis_law_ajel_lindsayfox_by_pixabay.jpg?width=1200&height=800&fit=crop)
Medical cannabis company Better (Cann Pharmaceuticals Ltd.) is suing InterCure (NASDAQINCR) for $35 million.
Via Benzinga · June 15, 2023
![](https://cdn.benzinga.com/files/images/story/2023/05/16/finance_and_marijuana_kindel_media_by_pexels.jpg?width=1200&height=800&fit=crop)
InterCure Ltd. (NASDAQINCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) released its financial results for the first quarter ended March 31, 2023, revealing revenue of NIS 106 million ($29 million) representing 22% growth YoY and up 1% sequenti
Via Benzinga · May 16, 2023
![](https://cdn.benzinga.com/files/images/story/2023/04/27/15.png?width=1200&height=800&fit=crop)
Cannabis stocks shot up in Thursday's pre-market and are holding.
Via Benzinga · April 27, 2023
![](https://cdn.benzinga.com/files/images/story/2023/04/20/cannabis_signing_document_jarmoluk_and_lindsayfox_by_pixabay.jpg?width=1200&height=800&fit=crop)
InterCure Ltd. (NASDAQINCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) and TYSON 2.0 have entered into a binding letter of intent for a business partnership.
Via Benzinga · April 20, 2023
![](https://cdn.benzinga.com/files/images/story/2023/04/03/image48.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping around 80 points on Monday. The Dow traded up 0.89% to 33,571.43 while the NASDAQ fell 0.66% to 12,142.07. The S&P 500, also rose, gaining, 0.17% to 4,116.15.
Via Benzinga · April 3, 2023
![](https://cdn.benzinga.com/files/images/story/2023/04/03/heska_-_logo.jpg?width=1200&height=800&fit=crop)
Gainers Nogin, Inc. (NASDAQNOGN) shares surged 172.4% to $7.41. Guardforce AI Co., Limited NASDAQ: GFAINASDAQGFAI)
Via Benzinga · April 3, 2023
![](https://cdn.benzinga.com/files/images/story/2023/04/03/image45.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite dropping more than 100 points on Monday. The Dow traded up 0.58% to 33,468.38 while the NASDAQ fell 0.96% to 12,104.67. The S&P 500, also fell, dropping, 0.10% to 4,105.19.
Via Benzinga · April 3, 2023